Petr Šimon Selected Research

Nucleotides

1/2021	Phosphate linkers with traceable cyclic intermediates for self-immolation detection and monitoring.
1/2019	MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Petr Šimon Research Topics

Disease

1	COVID-19 01/2021
1	Inflammation (Inflammations) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019

Drug/Important Bio-Agent (IBA)

2	NucleotidesIBA 01/2021 - 01/2019
1	ProdrugsIBA 01/2021
1	ProTidesIBA 01/2021
1	remdesivirIBA 01/2021
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2019
1	InflammasomesIBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2019

Therapy/Procedure

1	Therapeutics 01/2019